May 1
Got Ozempic Breath? & Goblins Infiltrate ChatGPT
Episode 836: Neal and Toby discuss the GDP report of the US economy which showed a solid growth of 2%, boosted by the all-out spending on AI. Next, Apple tops their quarterly earnings on strong iPhone sales, perhaps a promising sign for the post-Tim Cook era. Then, Ozempic might ... Show More
27m 54s
Apr 30
Jerome Powell Ain’t Leavin’ Yet & Movie Tickets Cost $50!?
Episode 835: Neal and Toby do a roundup of major tech earnings coming from Microsoft, Meta, Alphabet, and Amazon. Then, the Federal Reserve keeps rates steady in what is likely Jerome Powell’s last policy meeting as leader. Next, Neal shares numbers on the $50 movie ticket, predi ... Show More
29m 14s
Apr 29
OpenAI’s Struggles Spooks Tech Stocks & UAE Walks Away From OPEC
Episode 834: Neal and Toby chat about the United Arab Emirates leaving OPEC next month, after six decades of membership, and how it’ll impact the global oil supply. Next, OpenAI reports missing key revenue targets, which sends companies linked to the ChatGPT-maker into a tailspin ... Show More
28m 5s
Apr 2025
How the War on Drugs got us... blueberries
Ever wondered why you can buy fresh Peruvian blueberries in the dead of winter? The answer, surprisingly, is tied to cocaine. Today on the show, we look at how the War on Drugs led to an American trade policy and a foreign aid initiative that won us blueberries all year round. An ... Show More
27m 57s
Episode 335: Neal and Toby discuss what it would mean if the FDA approves MDMA to be used as a PTSD treatment. Then, Elon Musk pleads with Tesla shareholders to approve of his $47 billion pay package. Also, live entertainment is taking a hit with concert-goers cutting back on spending and artists canceling their tours. Next, Mexico and Dr. Pepper are the wee ... Show More
